Study Group: Generic Drug Economic Experts(?)
Council Members in this Study Group: 586
Request a survey with this Study Group
Leading Experts in this Study Group
![]() |
What is a GLG Leader? |
Principal
GordonBearcatResearch.com
Bill Kelley is the Principal of GordonBearcatResearch.com. Mr. Kelley specializes in several retailing businesses which are specified on his website. He works with investors, private equity specialists, and other consultants. Mr. Kelley was the Chairman, President and CEO of Consolidated Stores Corp....
Taral Patel, MDOncologist
Mid Ohio Oncology Hematology Inc.
Taral Patel, MD, is an Oncologist in private practice with Mid Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been a principal investigator for multiple clinical trials in colon cancer, lung cancer, lymphoma, and growth factor. He has been on the...
Dea Belazi, PharmD, MPH, PAHMPharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM
Dea Belazi, PharmD, MPH, PAHM, is currently a consultant working with health plans and pharmaceutical companies. He was previously the Senior Director of Pharmacy Services for Independence Blue Cross, a large commercial and Medicare health plan in Pennsylvania. Prior to this position, he was the Associate...
Eric Gruff, PhD MBAPrincipal
E4 Consulting
Eric Gruff, PhD, MBA, BS, is the Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has over 16 years of experience in the pharmaceutical and biotech sector, including leadership roles at Pfizer, Agouron Pharmaceuticals,...
President
Insurance Insights
Bilyana Savic is the President of Insurance Insights. She is a consultant to insurance companies and insurance brokerage firms, specializing in the health insurance product categories of major medical, life, long term care, Medicare supplement, disability, accident and specified disease, but also with...
Hany SalamaDirector, Global Manufacturing and Pharmaceutical
Barrier Therapeutics
Hany Salama, ME, MBA, CPM, is the Director of Global Manufacturing and Pharmaceuticals at Barrier Therapeutics, Inc., New Jersey. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible...
Independent Consultant
Robert Dondes, Consultant
Robert Dondes is an Independent Consultant based in the mid-Atlantic United States, with headquarters in Maryland. His private practice focuses on managed care, health insurance, strategic analysis, and operational improvement. Mr. Dondes is affiliated with the consulting division of the Pennsylvania...
Adam Fein, PhDFounder & President
Pembroke Consulting Inc
Adam Fein, PhD, is the Founder and President of Pembroke Consulting, Inc., a Philadelphia-based management advisory and business research firm. Dr. Fein is one of the country’s foremost experts on pharmacy economics and the pharmaceutical supply chain. He provides strategic advisory services to a diverse...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Pharmacists (US) | 2075 |
| Experts on Generic Pharmaceuticals: Pharmacists | 96 |
| Formulary Design Experts | 157 |
| Economic Experts on Managed Care | 597 |
| Managed Care Experts | 526 |
| Medicare Experts | 419 |
| Economic Experts on Pharmacy Benefit Management Services | 71 |
GLG NewsSMAnalyses by this Study Group's Experts(?)
Drugs are released to the market without adequate study, then, after around 70 to 100 patient deaths due to the drug are reported, the drug is pulled from the market. Getting in front of this "problem" would improve the safety of our drug supply.
A new report from Accenture attempts to assess the financial costs of implementing a serialized track-and-trace system for the U.S. pharmacy supply chain. But even if we assume that Accenture did a credible and impartial job building their pharmacy cost models, the estimates in this report reflect an...
Perpetual also-ran Rite-Aid (RAD) reported another quarter of weak results. When Rite-Aid Brooks/Eckerd came together in August 2006, the deal seemed to make sense given the marketplace dynamics although none of the companies were as well run as CVS or Walgreens. However, the company’s ongoing struggles...
Walgreens (WAG) has begun touting its Walgreens Prescription Savings Club, which offers a 3-month supply of over 400 generics for $12.99 (plus an annual membership fee). Walgreens latest move suggests that the low-priced generic wave is having a bigger effect that many people (including me) expected....
Drug company (Roche) retaliates against an agency that speaks the truth about their chemical - that it's cost is not worth the minimal benefit. This will become more common as time goes on, even here in the bastion of capitalism.
GLG InstituteSM
Seminars with this Study Group's Leaders(?)
Recent Seminars
Most Common Company Types:
- Pharmaceuticals Manufacturer
- Academic Medical Center/Hospital or Clinic
- Consultancy, Pharma-Focused
- Pharmacy or Drug Store, Chain
- Office Based Private Practice or Clinic
- Consultancy, Healthcare-Focused
- Pharmacy or Drug Store, Independent/Local
- Individual/Small Consultancy
Most Common Job Types:
- Director
- President
- Pharmacist - RPh/PharmD
- Owner
- Physician - Attending Physician
- Chief Executive Officer
- Principal
- Consultant
- Manager
- Physician - Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms


